| scholarly article | Q13442814 |
| P2093 | author name string | Ratnoff OD | |
| Breckenridge RT | |||
| P2860 | cites work | STUDIES ON THE SITE OF ACTION OF A CIRCULATING ANTICOAGULANT IN DISSEMINATED LUPUS ERYTHEMATOSUS. EVIDENCE THAT THIS ANTICOAGULANT INHIBITS THE REACTION BETWEEN ACTIVATED STUART FACTOR (FACTOR X) AND PROACCELERIN (FACTOR V) | Q76640482 |
| STUDY OF THE INHIBITION OF AUTOPROTHROMBIN C ACTIVITY | Q76851308 | ||
| The coagulation of blood by Russell's viper venom; a reaction between Russell's viper venom and beef serum factors | Q77219175 | ||
| Anticoagulant action of protamine sulphate | Q78239426 | ||
| Some pharmacologic characteristics of hexadimethrine bromide (polybrene); a new antiheparin agent | Q78576926 | ||
| A Simple Assay Method for Factor x (Stuart-Prower Factor) | Q78930183 | ||
| The Coagulant Action of Russell's Viper Venom; The Use of Antivenom in Defining its Reaction with a Serum Factor | Q78995094 | ||
| The effect of Polybrene on blood coagulation. In vitro | Q79029017 | ||
| Pathways to blood coagulation product I formation | Q79620986 | ||
| Autoprothrombin C in irregular blood clotting | Q79662473 | ||
| Kinetics of conversion of prothrombin to thrombin by biological activators. I. Demonstration of a prothrombin derivative which reacts with proteolytic enzyme inhibitors | Q79667407 | ||
| Studies on the action of Hageman factor: evidence that activated Hageman factor in turn activates plasma thromboplastin antecedent | Q34011088 | ||
| AN ENZYME CASCADE IN THE BLOOD CLOTTING MECHANISM, AND ITS FUNCTION AS A BIOCHEMICAL AMPLIFIER. | Q34257237 | ||
| WATERFALL SEQUENCE FOR INTRINSIC BLOOD CLOTTING. | Q34257361 | ||
| The site of inhibition of blood clotting by soy bean trypsin inhibitor | Q35188486 | ||
| The influence of calcium ions on the inactivation of human complement and its components by plasmin | Q36262111 | ||
| Thrombokinase of the Blood as Trypsin-Like Enzyme | Q36374138 | ||
| OUTSTANDING CHARACTERISTICS OF THROMBOKINASE ISOLATED FROM BOVINE PLASMA. | Q36374474 | ||
| A new adsorption agent for coagulation factors | Q36704326 | ||
| EFFECT OF BLOOD PROTEASE AND TRYPSIN INHIBITOR ON THE CLOTTING MECHANISM. | Q40996538 | ||
| The assay and properties of labile factor (factor V) | Q41287651 | ||
| The fractionation of Russell's-viper (Vipera russellii) venom with special reference to the coagulant protein | Q41903987 | ||
| Effect of blood thrombokinase, as influenced by soy bean trypsin inhibitor, ultracentrifugation, and accessory factors | Q42049232 | ||
| The isolation and purification of a bovine-plasma protein which is a substrate for the coagulant fraction of Russell's-viper venom | Q42283834 | ||
| Studies on the nature of the circulating anticoagulant directed against antihemophilic factor: with notes on an assay for anthemophilic factor | Q45867143 | ||
| PURIFICATION AND PROPERTIES OF BOVINE FACTOR V: A CHANGE OF MOLECULAR SIZE DURING BLOOD COAGULATION. | Q47422013 | ||
| The reaction of blood coagulation factors with brain extract. | Q51336787 | ||
| On the evolution of blood clotting theory | Q73030592 | ||
| Prothrombin and accessory factors; clinical significance | Q73042377 | ||
| Fundamentals of blood clotting | Q73949876 | ||
| Parahemophilia in three siblings (Owren's disease) | Q73979193 | ||
| Intermediate stages in the formation of blood thromboplastin | Q74012976 | ||
| The role of factor V in the formation of blood thromboplastin | Q74528882 | ||
| Intermediate reactions in the coagulation of blood with tissue thromboplastin; convertin, accelerin, prothrombinase | Q74585946 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | anticoagulant | Q215118 |
| protamine sulfate | Q22075855 | ||
| anticoagulation | Q63279445 | ||
| P304 | page(s) | 302-314 | |
| P577 | publication date | 1965-02-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | The Role of Proaccelerin in Human Blood Coagulation. Evidence that Proaccelerin Is Converted to a Prothrombin-converting Principle by Activated Stuart Factor: With Notes on the Anticoagulant Action of Soybean Trypsin Inhibitor, Protamine Sulfate, an | |
| P478 | volume | 44 |
| Q70485366 | Behaviour of Factor V and Factor VIII during the Process of Blood Coagulation |
| Q53754727 | Conversion of the fourth complement component studied by crossed immunoelectrophoresis. |
| Q53030053 | Epidemiological aspects of magnesium and calcium metabolism. Implications of altered magnesium metabolism in women taking drugs for the suppression of ovulation. |
| Q72355874 | Experiments on the Nature of the Prothrombin-Converting Principle: Alteration of Proaccelerin Thrombin |
| Q59060846 | Formation of Prothrombin Converting Activity |
| Q34275643 | Inhibition of Hageman factor activation |
| Q36269052 | Mechanisms of activation of C'1 esterase in hereditary angioneurotic edema plasma in vitro |
| Q36078257 | Participation of components of the blood coagulation system in the inflammatory response |
| Q35568955 | Permeability-increasing activity in hereditary angioneurotic edema plasma. II. Mechanism of formation and partial characterization |
| Q59054240 | Relationship between Factor V and Activated Factor X in the Generation of Prothrombinase |
| Q58964468 | Sequence Theories of Blood Coagulation re-evaluated with reference to Lipid–Protein Interactions |
| Q71203250 | Snake venoms as modifying agents of blood coagulation |
| Q39912861 | The Normal Coagulation Mechanism |
| Q41013869 | The anticoagulant activity of lysosomal cationic proteins from polymorphonuclear leukocytes |
| Q72388599 | The role of heparin in intrinsic blood coagulation |
Search more.